These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17502122)

  • 21. Synthesis and biological activities of 7-aza rebeccamycin analogues bearing the sugar moiety on the nitrogen of the pyridine ring.
    Messaoudi S; Anizon F; Peixoto P; David-Cordonnier MH; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2006 Nov; 14(22):7551-62. PubMed ID: 16889964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and cytotoxicities of 7-aza rebeccamycin analogues bearing various substituents on the sugar moiety, on the imide nitrogen and on the carbazole framework.
    Messaoudi S; Anizon F; Léonce S; Pierré A; Pfeiffer B; Prudhomme M
    Eur J Med Chem; 2005 Oct; 40(10):961-71. PubMed ID: 15907347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of novel pyrrolo[2,3-a]carbazoles: 7-Chloro-2-oxo-3a-(2'-oxo-2',3'-dihydro-1'H-indol-3'-yl)-2,3,3a,4,5,10-hexahydro-pyrrolo[3,2-a]carbazole-1-carbonitrile as an efficient anticancer agent.
    Sathiyachandran P; Manogaran P; Nesterov VN; Padma VV; Rajendra Prasad KJ
    Eur J Med Chem; 2018 Apr; 150():851-863. PubMed ID: 29597168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models.
    Hudkins RL; Diebold JL; Tao M; Josef KA; Park CH; Angeles TS; Aimone LD; Husten J; Ator MA; Meyer SL; Holskin BP; Durkin JT; Fedorov AA; Fedorov EV; Almo SC; Mathiasen JR; Bozyczko-Coyne D; Saporito MS; Scott RW; Mallamo JP
    J Med Chem; 2008 Sep; 51(18):5680-9. PubMed ID: 18714982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel 5,7-disubstituted 6-amino-5H-pyrrolo[3,2-b]pyrazine-2,3-dicarbonitriles, the promising protein kinase inhibitors with antiproliferative activity.
    Dubinina GG; Platonov MO; Golovach SM; Borysko PO; Tolmachov AO; Volovenko YM
    Eur J Med Chem; 2006 Jun; 41(6):727-37. PubMed ID: 16675067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships of indole compounds derived from combretastatin A4: synthesis and biological screening of 5-phenylpyrrolo[3,4-a]carbazole-1,3-diones as potential antivascular agents.
    Ty N; Dupeyre G; Chabot GG; Seguin J; Quentin L; Chiaroni A; Tillequin F; Scherman D; Michel S; Cachet X
    Eur J Med Chem; 2010 Sep; 45(9):3726-39. PubMed ID: 20538383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution.
    Palmer BD; Thompson AM; Booth RJ; Dobrusin EM; Kraker AJ; Lee HH; Lunney EA; Mitchell LH; Ortwine DF; Smaill JB; Swan LM; Denny WA
    J Med Chem; 2006 Aug; 49(16):4896-911. PubMed ID: 16884302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.
    Deslandes S; Chassaing S; Delfourne E
    Mar Drugs; 2009 Dec; 7(4):754-86. PubMed ID: 20098609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1.
    Gazzard L; Williams K; Chen H; Axford L; Blackwood E; Burton B; Chapman K; Crackett P; Drobnick J; Ellwood C; Epler J; Flagella M; Gancia E; Gill M; Goodacre S; Halladay J; Hewitt J; Hunt H; Kintz S; Lyssikatos J; Macleod C; Major S; Médard G; Narukulla R; Ramiscal J; Schmidt S; Seward E; Wiesmann C; Wu P; Yee S; Yen I; Malek S
    J Med Chem; 2015 Jun; 58(12):5053-74. PubMed ID: 25988399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II.
    Desplat V; Moreau S; Gay A; Fabre SB; Thiolat D; Massip S; Macky G; Godde F; Mossalayi D; Jarry C; Guillon J
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):204-15. PubMed ID: 20222763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds.
    Bouaziz Z; Issa S; Gentili J; Gratz A; Bollacke A; Kassack M; Jose J; Herfindal L; Gausdal G; Døskeland SO; Mullié C; Sonnet P; Desgrouas C; Taudon N; Valdameri G; Di Pietro A; Baitiche M; Le Borgne M
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):180-8. PubMed ID: 24697298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 2 (JAK2).
    Liu Q; Batt DG; Lippy JS; Surti N; Tebben AJ; Muckelbauer JK; Chen L; An Y; Chang C; Pokross M; Yang Z; Wang H; Burke JR; Carter PH; Tino JA
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4265-9. PubMed ID: 26320619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrrolo[2,3-a]carbazoles as potential cyclin dependent kinase 1 (CDK1) Inhibitors. Synthesis, biological evaluation, and binding mode through docking simulations.
    Fousteris MA; Papakyriakou A; Koutsourea A; Manioudaki M; Lampropoulou E; Papadimitriou E; Spyroulias GA; Nikolaropoulos SS
    J Med Chem; 2008 Feb; 51(4):1048-52. PubMed ID: 18232654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ruthenium half-sandwich complexes as protein kinase inhibitors: derivatization of the pyridocarbazole pharmacophore ligand.
    Pagano N; Maksimoska J; Bregman H; Williams DS; Webster RD; Xue F; Meggers E
    Org Biomol Chem; 2007 Apr; 5(8):1218-27. PubMed ID: 17406720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concise synthesis of carbazole-1,4-quinones and evaluation of their antiproliferative activity against HCT-116 and HL-60 cells.
    Nishiyama T; Hatae N; Yoshimura T; Takaki S; Abe T; Ishikura M; Hibino S; Choshi T
    Eur J Med Chem; 2016 Oct; 121():561-577. PubMed ID: 27318980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion of carbazole carboxamide based reversible inhibitors of Bruton's tyrosine kinase (BTK) into potent, selective irreversible inhibitors in the carbazole, tetrahydrocarbazole, and a new 2,3-dimethylindole series.
    Liu Q; Batt DG; Chaudhry C; Lippy JS; Pattoli MA; Surti N; Xu S; Carter PH; Burke JR; Tino JA
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3080-3084. PubMed ID: 30097367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antifungal evaluation of 6-hydroxy-1H-carbazole-1,4(9H)-diones.
    Ryu CK; Lee SY; Kim NY; Hong JA; Yoon JH; Kim A
    Bioorg Med Chem Lett; 2011 Jan; 21(1):427-30. PubMed ID: 21075635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.
    Akue-Gedu R; Debiton E; Ferandin Y; Meijer L; Prudhomme M; Anizon F; Moreau P
    Bioorg Med Chem; 2009 Jul; 17(13):4420-4. PubMed ID: 19477650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antiproliferative activity of clausine E, mukonine, and koenoline bioisosteres.
    Liger F; Popowycz F; Besson T; Picot L; Galmarini CM; Joseph B
    Bioorg Med Chem; 2007 Aug; 15(16):5615-9. PubMed ID: 17548198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of pyrazole derivatives as potential multi-kinase inhibitors in hepatocellular carcinoma.
    Strocchi E; Fornari F; Minguzzi M; Gramantieri L; Milazzo M; Rebuttini V; Breviglieri S; Camaggi CM; Locatelli E; Bolondi L; Comes-Franchini M
    Eur J Med Chem; 2012 Feb; 48():391-401. PubMed ID: 22227043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.